ADIPOQ and Abdominal obesity: Regarding metabolic risks, adiponectin concentrations were lower in the presence of risk based on the waist–height index (p < 0.01), hypoalphalipoproteinemia (p < 0.01), and abdominal obesity (p < 0.05) (Figure 2).